Scopus h-index:18

Article:25

Review Article:6

Comment/Debate:1

Letter:1

Editorial:1

Chapter:2

Selected Publications

• AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma
• Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878](S0168827821003263)(10.1016/j.jhep.2021.04.049)
• Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
• The Liver and Insulin Resistance: The Important Convergence of Endocrinology and Hepatology
• Hemophagocytic lymphohistiocytosis due to primary HHV-8 infection in a liver transplant recipient
• Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
• Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
• Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
• High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens
• Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening